Picture of Odi Pharma AB (publ) logo

ODI — Odi Pharma AB (publ) Balance Sheet

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Odi Pharma AB (publ), fiscal year end - June 30th, SEK millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalPreliminary
Cash
Cash and Equivalents
Cash and Short Term Investments7.376.492.641.483.39
Net Total Accounts Receivable
Net Total Receivables1.090.8138.981.491.04
Total Inventory
Prepaid Expenses
Total Current Assets10.58.1812.23.615.29
Net Property, Plant And Equipment0.0120.0090.0060.0040.011
Other Long Term Assets
Total Assets10.58.1912.24.615.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities1.245.6110.24.192.93
Total Long Term Debt
Total Debt
Total Liabilities1.245.6110.24.192.93
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity9.262.5720.4252.38
Total Liabilities & Shareholders' Equity10.58.1912.24.615.3
Total Common Shares Outstanding